secwatch.observer — SEC 8-K summary
======================================

Issuer:     IR-Med, Inc. (—)
CIK:        0001839133
Form:       8-K
Filed at:   2026-02-05T23:59:59+00:00
Accession:  0001493152-26-005258
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 1.01, 3.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IR-Med raises $43,619 from director-led private placement; CEO Ran Ziskind resigns
--------------------------------------------------------------------------------

- Gross proceeds of $43,619 from sale of 14,070,644 shares at $0.0031 and warrants for 7,035,322 shares at $0.03.
- Directors Oded Bashan, Yaniv Cohen, Yechiel Even, Ron Mayron, and Aharon Klein participated in the offering.
- CEO Ran Ziskind resigned effective February 3, 2026, citing disagreements on strategic direction and management.
- Warrants have a 5-year term and are immediately exercisable at $0.03 per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1839133/000149315226005258/0001493152-26-005258-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1839133/000149315226005258/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-005258

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer